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Edited by Frances ShannonAbstract Chrysin is a natural, biologically active compound ex-
tracted from many plants, honey and propolis. It possesses
potent anti-inﬂammation, anti-cancer and anti-oxidation proper-
ties. The mechanism by which chrysin suppresses COX-2 expres-
sion remains poorly understood. In the present report, we
investigated the eﬀect of chrysin on the expression of COX-2
in lipopolysaccharide (LPS)-activated Raw 264.7 cells. Chrysin
signiﬁcantly suppressed the LPS-induced COX-2 protein and
mRNA expression in a dose-dependent manner. The ability of
chrysin to suppress the expression of the COX-2 was investi-
gated using luciferase reporters controlled by various cis-ele-
ments in COX-2 promoter region. Mutational analysis and
electrophoretic mobility shift assay veriﬁed that nuclear factor
for IL-6 was identiﬁed as responsible for the chrysin-mediated
COX-2 downregulation. These results will provide new insights
into the anti-inﬂammatory and anti-carcinogenic properties of
chrysin.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Prostaglandins play important roles in many cellular re-
sponses including cell growth, ovulation, and immune func-
tions, and inhibition of their synthesis is the target of most
known nonsteroidal anti-inﬂammatory drugs [1,2]. Prostaglan-
dins synthesis involve phospholipase catalyzed release of ara-
chidonic acid from membranes phospholipids and its
conversion by the two cyclooxygenase (Cox) enzymes to pros-
taglandins [2,3]. Cox-1 is constitutively expressed in tissues and
is thought to be involved in homeostatic prostanoid biosynthe-
sis [2–4]. COX-2 is thought to be the predominant isoform in-
volved in the inﬂammatory responses [2–4]. Multiple lines of
evidence suggest that COX-2 has a signiﬁcant role in carcino-
genesis. COX-2 is overexpressed in transformed cells as well as
in various forms of cancer [5–7], because the targeted inhibi-
tion of COX-2 is a promising approach to inhibiting inﬂamma-
tion and carcinogenesis as well as to prevent cancer.*Corresponding author. Fax: +82 53 250 7074.
E-mail address: kwontk@dsmc.or.kr (T.K. Kwon).
0014-5793/$30.00  2005 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2004.12.048The ﬂavonoids are a diverse family of chemicals commonly
found in fruits and vegetables. Flavonoids are plant polyphe-
nolic compounds, which comprise several classes including
ﬂavonols, ﬂavanones, ﬂavanols and ﬂavans. Chrysin (5,7-
dihydroxyﬂavone) is a natural ﬂavonoid contained in many
plant extracts, honey and propolis [8,9]. Recent studies have
shown that chrysin inhibits activation of human immunodeﬁ-
ciency virus in models of latent infection [10]. Several studies
in recent years have shown that chrysin has multiple biological
activities, such as anti-inﬂammation, anti-cancer and anti-
oxidation eﬀects [11–14]. Recently, some ﬂavonoids including
chrysin exhibited weak peroxisome proliferator-activated
receptor-c (PPAR-c) agonist activities in an in vitro competi-
tive-binding assay [15]. The PPAR-c agonists have been con-
sidered to inhibit production of monocyte inﬂammatory
cytokines and expression of inducible nitric oxide synthase
and COX-2 [16]. However, the cellular and molecular mecha-
nisms underlying chrysin-induced inhibition of COX-2 expres-
sion in macrophages are not clear.
In this study of chrysin anti-inﬂammatory properties, chry-
sin inhibited LPS-induced COX-2 expression in Raw 264.7
cells, apparently through blockading NF-IL6 binding to the
COX-2 promoter, thereby inhibiting COX-2 expression.2. Materials and methods
2.1. Cells and materials
All reagents were purchased from Sigma–Aldrich unless otherwise
stated. Chrysin [(5,7-dihydroxyﬂavone) (Fig. 1)] was dissolved in di-
methyl sulfoxide and freshly diluted in culture media for all in vitro
experiments. The macrophage cell line Raw 264.7 was obtained from
the American Type Culture Collection (Rockville, MD) and cultured
in RPMI 1640 supplemented with 2 mM of L-glutamine, 100 U/ml
penicillin, 100 lg/ml streptomycin, and 10% fetal calf serum. The cells
were subcultured twice weekly and grown on 6-well plates at
1 · 106cells/well, at 37 C in fully humidiﬁed 5% CO2 air. Anti-COX-
2 and anti-NF-IL6 were purchased from Santa Cruz Biotechnology
Inc. Anti-phospho-ERK, anti-phospho-JNK, and anti-phospho-p38
MAPK were purchased from New England Biolabs Inc. The inhibitors
PD98059, SB203580, SP600125, genistein, and tyrphostin A 23 were
purchased from Biomol.
2.2. Western blotting
Cellular lysates were prepared by suspending 1.5 · 106 cells in 100 ll
of lysis buﬀer (137 mM NaCl, 15 mM EGTA, 0.1 mM sodium ortho-
vanadate, 15 mM MgCl2, 0.1% Triton X-100, 25 mM MOPS (4-mor-
pholinepropane-sulfonic acid), 100 lM phenylmethylsulfonyl ﬂuoride,blished by Elsevier B.V. All rights reserved.
Fig. 1. Chemical structure of chrysin (5,7-dihydroxyﬂavone).
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extracted at 4 C for 30 min. The proteins were electrotransferred to
Immobilon-P membranes and detection of speciﬁc proteins was carried
out with an ECL Western blotting kit according to the manufacturers
instructions.
2.3. RNA isolation and reverse transcriptase-polymerase chain reaction
(RT-PCR)
Total RNA was isolated according to Chomczynski and Sacchi [17].
Single-strand cDNA was synthesized from 2 lg of total RNA using
Moloney–Murine leukemia virus reverse transcriptase. The cDNA for
COX-2 and actin were PCR ampliﬁed using the following speciﬁc prim-
ers: COX-2 (sense) 5 0-CCGTGGTGAATGTATGAGCA-3 0 and (anti-
sense) 5 0-CCTCGCTTCTGATCTGTCTT-3 0. PCR ampliﬁcation was
carried out as follows: 1· (94 C, 3 min); 30· (94 C, 45 s; 59 C, 45 s;
and 72 C, 1 min); and 1· (72 C, 10 min). PCR products were analyzed
by agarose gel electrophoresis and visualized by ethidium bromide.
2.4. DNA transfection and luciferase assay
Nuclear factor-jB (NF-jB) reporter constructs were purchased from
Clontech. The human COX-2 promoter-containing plasmids have been
described previously [18,19]. NF-jB reporter plasmids or COX-2 pro-
moter plasmids were transfected into Raw 264.7 cells using the Lipo-
fectamine reagent according to the manufacturers instructions. ToFig. 2. Eﬀect of chrysin on LPS-induced expression of COX-2 protein and mR
chrysin in the presence of LPS (50 ng/ml) for 12 h. The cells were lysed, and th
was stripped of the bound antibody and reprobed with anti-ERK antibody
analysis was performed as described in Section 2. (C) Raw 264.7 cells were
(2.5 lM) in the presence of actinomycin D (5 lg/ml) for the indicated time
representative result is shown; two additional experiments yielded similar reassess COX-2 promoter driving of the luciferase gene, cells were col-
lected and disrupted by sonication in lysis buﬀer (25 mM tris-phos-
phate, pH 7.8, 2 mM EDTA, 1% Triton X-100, and 10% glycerol).
After centrifugation, aliquots of the supernatants were analyzed with
the luciferase assay according to the manufacturers instructions.
2.5. Nuclear extract preparation and electrophoretic mobility shift assay
(EMSA)
Preparation of nuclear extracts from control or drug-treated cells
was carried out as described previously [20]. The sequences of the dou-
ble-stranded oligonucleotides used to detect the DNA-binding activi-
ties of NF-jB, cAMP response element-binding protein (CREB),
and NF-IL6 (CCAAT/enhancer-binding protein, C/EBP) are as fol-
lows: NF-jB, 5 0-AGT TGAGGGGAC TTT CCC AGG C-3 0; CREB,
5 0-AGA GAT TGC CTG ACG TCA GAG AGC TAG-3 0; and NF-
IL6 (C/EBP), 5 0-TGC AGA TTG CGC AAT CTG CA-3 0. The reac-
tion mixture for EMSA contained 20 mM Tris–HCl, pH 7.6, 1 mM
dithiothreitol, 2 mM MgCl2, 1 mM EDTA, 10% glycerol, 1% NP-40,
1 lg of poly(dI-dC) and 5 lg nuclear proteins. Unlabeled wild type oli-
gonucleotide was added into the reaction mixture and incubated for 10
min at room temperature. [32P]-labeled probe DNA (300000 cpm) was
added, and the binding reaction was allowed to proceed for another
20 min. Mixtures were resolved on 8% polyacrylamide gels at 150 V
for 4 h. Gels were dried and subjected to autoradiography.3. Results
3.1. Chrysin inhibition of LPS-induced COX-2 mRNA and
protein expression in RAW 264.7 cells
Unstimulated Raw 264.7 cells do not contain COX-2,
whereas addition of 50 ng/ml LPS induced COX-2 synthesis
in these cells (Fig. 2A). To investigate whether chrysin can in-
hibit LPS-induced COX-2 expression, Raw 264.7 cells were
pretreated for 30 min with various concentrations of chrysin
and subsequently treated with 50 ng/ml LPS. Cells pretreatedNA. (A) Raw 264.7 cells were treated with indicated concentrations of
e lysates were analyzed by immunoblotting using anti-COX-2. The blot
to conﬁrm equal loading. (B) Total RNA was prepared and RT-PCR
treated with 50 ng/ml LPS for 8 h and then with or without chrysin
s. Total RNA was isolated and RT-PCR analysis was performed. A
sults.
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protein expression following LPS stimulation. To assess the ef-
fect of chrysin on COX-2 mRNA expression, we measured
mRNA levels using RT-PCR. The expression of COX-2
mRNA was hardly detectable in unstimulated cells. Raw
264.7 cells that were not treated with chrysin expressed high le-
vel of COX-2 mRNA when stimulated with 50 ng/ml LPS for
12 h. Addition of chrysin inhibited this LPS-stimulated COX-2
mRNA production in a dose-dependent manner (Fig. 2B). We
also investigated whether chrysin stabilized COX-2 mRNA.
Raw 264.7 cells were treated with vehicle or LPS for 8 h to in-
duce COX-2 transcription, and then transcription was stopped
with the addition of actinomycin D. RNA was isolated at dif-
ferent time points after treatment with actinomycin D and sub-
jected to RT-PCR analysis. As shown in Fig. 2C, treatment
with chrysin did not cause a signiﬁcant change in the half-life
of COX-2 mRNA.
3.2. Eﬀect of chrysin on phosphorylation state of MAPKs and
tyrosine kinase activated by LPS
To investigate whether the ERK, JNK, and p38 MAPK
pathways are involved in LPS stimulation of Raw 264.7 cells,
we examined whether selective MAPK inhibitors could aﬀectFig. 3. Eﬀect of chrysin on LPS-induced phosphorylation of MAPKs and ty
with PD98059 (50 lM), SB203580 (10 lM) and SP600125 (20 lM) for 30
expression was determined by Western blot analysis. The blot was stripped of
equal loading. (B) Raw 264.7 cells were treated with vehicle, LPS (50 ng/m
amounts of lysates (40 lg) were subjected to electrophoresis and analyzed b
ascertain that the total level of each MAPK did not change, blots were strip
phosphorylation-independent MAPK. The results presented are representativ
with genistein (100 lM), chrysin (2.5 lM) and tyrphostin A23 (300 lM) for
expression was determined by Western blot analysis. The blot was stripped of
equal loading.LPS-stimulated COX-2 expression. SP600125 (a JNK inhibi-
tor) profoundly inhibited LPS-mediated COX-2 expression,
however, treatment with PD98059 (a MEK inhibitor) and
SB203580 (a p38 MAP kinase inhibitor) slightly decreased
COX-2 expression (Fig. 3A). To investigate whether the inhi-
bition of COX-2 expression by chrysin is mediated through
the modulation of the MAPK pathways, we examined the
activation of the three MAPKs by detecting their dually phos-
phorylated forms in Western blots probed with speciﬁc anti-
phosphokinase antibodies (Fig. 3B). LPS treatment induced
a strong transient increase in phosphorylated MAPKs levels,
which peaked at 30 min and declined thereafter. Overall,
LPS treatment of macrophages stimulated these three MAPKs
with similar kinetics. The phosphorylation of MAPKs was not
suppressed by cotreatment with LPS and chrysin (Fig. 3B).
Genistein and tyrphostin A23, inhibitors of tyrosine ki-
nase, were used to determine whether LPS-induced tyrosine
phosphorylation participated in the signaling pathways for
the COX-2 expression. Pretreatment of genistein and tyrpho-
stin A23 inhibited COX-2 expression by Raw264.7 cells fol-
lowing stimulation with LPS (Fig. 3C). To investigate
whether the tyrosine phosphorylation is involved in the chry-
sin-mediated inhibition of LPS-induced COX-2 expression,rosine kinase in Raw 264.7 cells. (A) Raw 264.7 cells were pretreated
min followed by stimulation with LPS (50 ng/ml) for 12 h. COX-2
the bound antibody and reprobed with anti-ERK antibody to conﬁrm
l), chrysin (2.5 lM) and LPS plus chrysin for indicated times. Equal
y immunoblotting using phosphorylation state-speciﬁc antibodies. To
ped and reprobed with the antibodies raised against the corresponding
e of three independent experiments. (C) Raw 264.7 cells were pretreated
30 min followed by stimulation with LPS (50 ng/ml) for 12 h. COX-2
the bound antibody and reprobed with anti-ERK antibody to conﬁrm
708 K.J. Woo et al. / FEBS Letters 579 (2005) 705–711the eﬀect of chrysin on phosphotyrosine accumulation in
stimulated cells exposed to LPS was studied. Chrysin did
not aﬀect in LPS-induced phosphotyrosine accumulations
(negative data not shown).
3.3. Chrysin inhibits COX-2 promoter activity
To investigate the mechanism underlying the chrysin-
mediated inhibition of LPS-induced COX-2 expression, we used
phPES2 (327/+59), a plasmid that expresses ﬁreﬂy luciferase
under the control of the human COX-2 gene promoter (327/
+59). The COX-2 promoter region (327/+59) contains three
cis-acting elements, namely, an NF-jB binding site, an NF-IL6
(C/EBP) binding sites, and a CREB, all of which have been
shown to be involved in the regulation of COX-2 gene tran-
scription. To identify which cis-acting elements play a critical
role in LPS-mediated COX-2 gene promoter (327/+59) activ-
ity, mutants of the three cis-acting element were made and
tested in transfection assay (Fig. 4A). A mutation in CREB
or NF-IL6 signiﬁcantly reduced the basal and LPS-induced
promoter activities. Mutation at the NF-jB site also inhibits
basal and LPS-induced promoter activities, but it show less
inhibitory eﬀect than that of CREB or NF-IL6. To examine
the eﬀect of chrysin on LPS-induced COX-2 promoter activi-
ties, a reporter assay was performed using phPES2 (327/
+57), phPES2 (CRM; mutant for CREB), phPES2 (ILM; mu-Fig. 4. Site-speciﬁc mutation of the COX-2 promoter region in response to ch
putative transcriptional regulatory element. Lowercase letters in the lower seq
shows wild-type bases. Wild type or mutant COX-2 promoters were transfec
activity measured. Data represent the means ± S.D. of at least three indepe
transfected, and treated with or without chrysin in the presence of LPS (50
experiments.tant for NF-IL6) and phPES2 (KBM; mutant for NF-jB). As
shown in Fig. 4B, chrysin inhibits twofold in LPS-induced
COX-2 promoter activities in the phPES2 (327/+57), phPES2
(CRM) and phPES2 (KBM) constructs transfected cells. How-
ever, chrysin-mediated COX-2 promoter inhibition measured
by LPS-driven luciferase activity is signiﬁcant less in the
phPES2 (ILM) construct than in the constructs with the wild
type, CREB-mutated promoter and NF-jB-mutated pro-
moter. These data suggest that NF-IL6 is mainly involved in
the chrysin-mediated inhibition of LPS-induced COX-2 pro-
moter activity.
3.4. Inhibition of NF-IL6 binding activity by chrysin in
LPS-induced Raw 264.7 cells
It is well known that NF-IL6 is an important transcription
factor for the expression of COX-2 gene by LPS [21,22]. To
determine whether these transcription factors are an impor-
tant target for chrysin in Raw 264.7 cells, we performed an
EMSA. Treatment of Raw 264.7 cells with 50 ng/ml LPS
caused a signiﬁcant increase in the DNA-binding activity of
NF-IL6 within 4 h. To conﬁrm that increasing bands were in-
deed NF-IL6 speciﬁc DNA–protein complexes, we tested
binding of wild-type oligonucleotides against that of a mu-
tant oligonucleotide lacking the NF-IL6 site. The wild-type
competitor inhibited LPS-induced NF-IL6 binding activity,rysin. (A) The COX-2 gene promoter (327/+59) was mutated at each
uence of each promoter indicate mutated bases, and the upper sequence
ted and treated with or without LPS (50 ng/ml) for 24 h and luciferase
ndent experiments. (B) Wild type or mutant COX-2 promoters were
ng/ml). Data represent the means ± S.D. of at least three independent
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binding. The identity of the NF-IL6 protein in this complex
was further conﬁrmed by a super-shift assay using an anti-
body speciﬁc to NF-IL6 (Fig. 5A). LPS-induced NF-IL6
binding was markedly decreased at 2.5 lM chrysin treatment
(Fig. 5A). The Western blot data suggest that NF-IL6 activ-
ity is not regulated NF-IL6 expression levels, because NF-IL6
protein expression of NF-IL6 remain unchanged regardless of
whether the Raw 264.7 cells were treated with LPS and chry-
sin or not (Fig. 5B).
To determine whether chrysin inhibits activation of CREB
and NF-jB through the inhibition of DNA binding of
CREB and NF-jB, we examined the eﬀect of chrysin on
LPS-induced binding of CREB and NF-jB by EMSA.
Chrysin did not aﬀect the intensity of the CREB DNA com-
plex induced by LPS or its migration in Raw 264.7 cells
(negative data not shown). In the presence of chrysin,
LPS-induced NF-jB binding was markedly increased in a
dose-dependent manner (Fig. 6A). To determine the eﬀect
of chrysin on LPS-stimulated NF-jB-dependent reporter
gene expression, we used a pNFjB-Luc plasmid, which
was generated by inserting four spaced NF-jB binding sites
into the pLuc-Promoter vector. Raw 264.7 cells were tran-
siently transfected with the pNFjB-Luc plasmid and then
stimulated with 50 ng/ml LPS either in the presence or ab-
sence of chrysin. Chrysin treatment signiﬁcantly increased
the LPS-induced increase in NF-jB-dependent luciferase en-
zyme expression (Fig. 6B). These results suggest that chry-
sin-mediated inhibition of LPS-induced COX-2 expression
is associated with inhibition of NF-IL6 DNA-binding activ-
ity, but not in CREB and NF-jB DNA-binding activity.Fig. 5. Eﬀect of chrysin on NF-IL6 DNA-binding activity in LPS-stimu
concentrations of chrysin for 30 min before incubation with LPS (50 ng/ml)
[32P]-labeled NF-IL6 oligonucleotide probe. Binding speciﬁcity was determin
NF-IL6 binding sequence (50-fold in excess) to compete with the labeled olig
super-shift analysis was performed using an antibody speciﬁc to NF-IL6. Sup
cells were pretreated with the indicated concentrations of chrysin for 30 min b
IL6 were determined by Western blot analysis.4. Discussion
Chrysin is known to have anti-inﬂammatory and anti-cancer
eﬀects. Here, we demonstrate that chrysin inhibits COX-2 gene
expression in LPS-stimulated cultured macrophages, and that
this eﬀect is mediated through the inhibition of NF-IL6
DNA-binding activity.
The regulation of COX-2 gene transcription is complex and
varies according to the cell type and the stimulus applied. Stud-
ies have shown that CREB, NF-jB, and NF-IL6 (C/EBP) were
commonly or individually involved in the regulation of the
COX-2 gene [21–26]. NF-jB exerts as a positive regulator of
several gene expressions involved in chronic inﬂammatory dis-
eases [27]. NF-jB signaling has been implicated variously in the
expression of COX-2 stimulated by several factors including
LPS [28–30]. Our ﬁndings indicate that NF-jB binding activity
and NF-jB luciferase activity are increased by treatment with
chrysin (Fig. 6A and B). This renders NF-jB as an unlikely tar-
get for the pharmacological actions of chrysin. In addition, the
mitogen-activated protein kinases play a critical role in the reg-
ulation of cell growth and diﬀerentiation and in the control of
cellular responses to cytokines and stresses [31]. Studies using
pharmacological inhibitors of MAPKs or their upstream pro-
tein kinase activators and dominant-negative mutant forms of
protein kinases demonstrated the role of ERK, JNK, and p38
MAPK in transcriptional activation of COX-2 [32–35]. More-
over, MAP kinases are involved in the signaling pathway for
LPS-induced COX-2 expression [22,36]. Hwang et al. [37] re-
ported that blockade of ERK and p38 MAPK activities by
PD98059 and SB203580, respectively, resulted in partial sup-
pression of LPS-induced expression of COX-2 in Raw 264.7lated cells. (A) Raw 264.7 cells were pretreated with the indicated
for 4 h. EMSA analysis of the nuclear extracts was conducted using a
ed using the unlabeled wild-type probe or mutant-type containing the
onucleotide. To identify whether the bound proteins contain NF-IL6,
er-shift with a rabbit IgG was used as a negative control. (B) Raw 264.7
efore incubation with LPS (50 ng/ml) for 4 h. Expression levels of NF-
Fig. 6. Eﬀect of chrysin on NF-jB DNA-binding activity and NF-jB
promoter activity. (A) Raw 264.7 cells were pretreated with the
indicated concentrations of chrysin for 30 min before incubation with
LPS (50 ng/ml) for 4 h. EMSA analysis of the nuclear extracts was
conducted using a [32P]-labeled NF-jB oligonucleotide probe. Binding
speciﬁcity was determined using the unlabeled wild-type probe or
mutant-type containing the NF-jB binding sequence (25-fold in
excess) to compete with the labeled oligonucleotide. (B) Cells were
transiently transfected with a pNFjB-Luc plasmid containing four
copies of the NF-jB binding site, treated with the indicated concen-
trations of chrysin and LPS for 24 h. The cells were lysed and luciferase
activity was measured. Data represent the means ± S.D. of at least
three independent experiments.
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that is involved in the chrysin-mediated inhibition of LPS-
induced COX-2 expression, we examined the eﬀects of chrysin
on the activation of MAPKs induced by LPS, ﬁnding that LPS-
induced MAPKs activations are not inhibited by chrysin.
Therefore, the eﬀect of chrysin on inhibition of LPS-induced
COX-2 expression is probably not associated with MAP kinase
activation.
NF-IL6, a member of the C/EBP family of transcription fac-
tors, is involved in inducing several acute-phase protein genes
in response to immune and inﬂammatory stimulation. NF-IL6
also plays a major role in inducing the expression of COX-2 by
cytokines (TNF-a and IL-1 b) and endotoxin [23,24,32]. Re-
cently, Gorgoni et al. [38], reported that COX-2 induction by
LPS was profoundly defective in C/EBP/ macrophages,
essentially due to impaired transcriptional induction via C/
EBP promoter element. Here, we demonstrate that chrysin
inhibits COX-2 gene expression in LPS-stimulated cultured
macrophages, and we propose that the actions of chrysin are
mediated by inhibition of NF-IL6 binding and transactivation.Several pieces of evidence support this proposal: (1) mutation
of the NF-IL6 site inhibits the stimulatory eﬀect of LPS, and
the inhibitory eﬀect of chrysin; (2) chrysin inhibited the
DNA-binding activity of NF-IL6; and (3) chrysin had not in-
hibit in LPS-induced NF-jB binding and transactivation.
In summary, chrysin inhibits LPS-induced COX-2 expression
in macrophages. These eﬀects are mediated, at least in part, by
inhibition of NF-IL6 activation. The fact that NF-IL6 is nega-
tively regulated by chrysin is important because this transcrip-
tion factor plays a critical role in the regulation of a variety of
genes involved in inﬂammatory responses. In view of the facts
that COX-2 plays an important role in mediating inﬂammatory
responses and that chrysin may be an important determinant of
clinical response in inﬂammatory diseases, further eﬀorts to ex-
plore this therapeutic strategy appear warranted.
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